Meningococcal disease in healthcare workers. Vaccine is available in Latin America.
作者信息
Trujillo C
出版信息
BMJ. 2000 Jan 22;320(7229):247; author reply 248-9.
Abstract
摘要
相似文献
1
Meningococcal disease in healthcare workers. Vaccine is available in Latin America.
BMJ. 2000 Jan 22;320(7229):247; author reply 248-9.
2
The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative.
Expert Rev Vaccines. 2013 Aug;12(8):903-15. doi: 10.1586/14760584.2013.814879. Epub 2013 Aug 5.
3
Meningococcal disease in travelers: update on vaccine options.
Curr Opin Infect Dis. 2012 Oct;25(5):507-17. doi: 10.1097/QCO.0b013e3283574c06.
4
Availability of meningococcal vaccine in single-dose vials for travelers and high-risk persons.
MMWR Morb Mortal Wkly Rep. 1990 Oct 26;39(42):763.
5
[Anti-meningococcal polysaccharide vaccines].
Enferm Infecc Microbiol Clin. 1997 Aug-Sep;15(7):347-8.
6
Preventing meningococcal infection in college students.
Clin Infect Dis. 2000 Apr;30(4):648-51. doi: 10.1086/313741. Epub 2000 Apr 20.
7
Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.
J Infect Dis. 1999 Jun;179(6):1569-72. doi: 10.1086/314753.
8
Meningococcal disease in São Paulo, Brazil.
NIPH Ann. 1991 Dec;14(2):215-6; discussion 216-8, 222-4.
9
Vaccine research: new vaccines and evidence of vaccine safety.
Commun Dis Rep CDR Wkly. 1999 May 7;9(19):167, 170.
10
Guidelines for controlling meningococcal disease.
CMAJ. 1992 Mar 15;146(6):939-42, 945-8.
本文引用的文献
1
Meningococcal disease and healthcare workers.
BMJ. 1999 Oct 30;319(7218):1147-8. doi: 10.1136/bmj.319.7218.1147.
2
Nosocomial meningococcemia in a physician.
Infect Control Hosp Epidemiol. 1999 Aug;20(8):564-5. doi: 10.1086/501672.
3
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
JAMA. 1999 Apr 28;281(16):1520-7. doi: 10.1001/jama.281.16.1520.
4
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.
J Infect Dis. 1998 Mar;177(3):683-91. doi: 10.1086/514232.
5
Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 1997 Feb 14;46(RR-5):1-10.
6
Secondary prevention of meningococcal disease.
BMJ. 1996 Mar 9;312(7031):591-2. doi: 10.1136/bmj.312.7031.591.
7
Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Int J Epidemiol. 1995 Oct;24(5):1050-7. doi: 10.1093/ije/24.5.1050.
8
Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group.
Commun Dis Rep CDR Rev. 1995 Dec 8;5(13):R189-95.
9
Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children.
Antimicrob Agents Chemother. 1995 Sep;39(9):2150-2. doi: 10.1128/AAC.39.9.2150.
10
Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis.
Lancet. 1993 May 1;341(8853):1152-3. doi: 10.1016/0140-6736(93)93171-v.
Zotero 插件